Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hager Pharma is a Germany-based healthcare and OTC distribution company focused on supplying pharmacies in Germany and Austria with products spanning health, lifestyle, and aesthetic categories. The business appears to operate primarily as a commercial-stage distributor and brand commercialization partner rather than a drug developer, helping place products into pharmacy channels with sales, merchandising, promotion, logistics, and seasonal marketing support. Hager Pharma is part of the broader Hager & Werken group and has distributed home-care prophylaxis products in the pharmacy sector since 2008. Its portfolio includes oral-care and consumer health products such as dry mouth, whitening, and prophylaxis-related offerings, alongside selected third-party brands. For a biotech analyst, this is best understood as a commercial healthcare products and OTC market access/distribution company, not a clinical-stage therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hager Pharma.